Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Impact · against what's priced in

Intuitive Surgical presents the most compelling opportunity as accelerating procedure growth is not reflected in a stock price that has fallen 17% over the last year. In contrast, Edwards Lifesciences and IQVIA offer limited upside as their recent price gains already reflect the recovery in procedure volumes and clinical trial activity.

ISRG+0.60: No priced-in read yet

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

What matters in this story

Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

What matters in this story

Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?

How each ticker is affected

Track these names every morning.

SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?

Natural Health Stock Plunges Post Q3 Earnings Despite Margin Gains

The EPS ‘Miss That Wasn't Gave You and Me an Opportunity to Scoop Up Alphabet Cheaply

UCTT Fell 31.6% in the Past Month: Is the Sell-Off an Opportunity?

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

What matters in this story

Next reads from the same story arc

Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

What matters in this story

Next reads from the same story arc

Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?

How each ticker is affected

Track these names every morning.

SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?

Natural Health Stock Plunges Post Q3 Earnings Despite Margin Gains

The EPS ‘Miss That Wasn't Gave You and Me an Opportunity to Scoop Up Alphabet Cheaply

UCTT Fell 31.6% in the Past Month: Is the Sell-Off an Opportunity?